| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eeaf21f4e6d1ac3b2ad65a697bd9b761 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2015-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7895e8c470c30646b8af781613cc73c0 |
| publicationDate |
2017-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3153160-A1 |
| titleOfInvention |
Use of xanthophylls for the treatment of cancers |
| abstract |
The present invention relates to a novel use of xanthophylls, particularly astaxanthin and/or an ester thereof, for inhibiting tumor cell growth. Therefore, the present invention provides a method for preventing or treating cancers, comprising administering to a subject in need thereof a composition comprising a therapeutically effective amount of at least one type of xanthophyll. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2612442-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4154874-A1 |
| priorityDate |
2015-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |